The Fund aims to produce steady capital growth over the long term by investing primarily in a portfolio of equities and related derivatives.The Fund will seek to achieve its objectives by holding investments which in the opinion of Investec, in aggregate, and particularly over the long term, offer a level of risk lower than that of the FTSE All Share Index.
Name | % Net Assets |
---|---|
Ruffer Investment Co Red Ptg Prf Shs | 6.2% |
Citigroup FTSE 100 ZEBRA 5.64 MAR 16 | 6.1% |
Artemis Strategic Assets | 5.1% |
UK Commercial Property | 4.1% |
Utilico Investment Trust ZDP 2012 | 3.4% |
Citigroup ULVR ZEBRA 5.36 MAR 16 | 3.3% |
Merrill Lynch BT ZEBRA 9.8 April 2015 | 2.9% |
Citigroup GSK ZEBRA 7.7 APR 15 | 2.7% |
Merrill Lynch Pfizer ZEBRA 7.9 April 2013 | 2.6% |
Barclays Philips ZEBRA 8.63 SEP 14 | 2.5% |
Key | % Net Assets |
---|---|
Ruffer Investment Co Red Ptg Prf Shs | 6.2% |
Citigroup FTSE 100 ZEBRA 5.64 MAR 16 | 6.1% |
Artemis Strategic Assets | 5.1% |
UK Commercial Property | 4.1% |
Other | 78.5% |
Date | 26-Feb-2021 |
---|---|
NAV | 231.48p |
Currency | GBP |
Change | -3.81p |
% | -1.62% |
YTD change | 231.48p |
YTD % | n/a |
Fund Inception | 19/07/1999 |
---|---|
Fund Manager | Alastair Mundy |
TER | 1.34 (30-Nov-2011) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £100 |
Savings | £100 |
Charges | |
---|---|
Initial | 4.50% |
Annual Mang't | 1.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.00 |
Sharpe ratio | 0.12 |
You are here: research